Treatment
Open-label Clinical Trial for anaplastic/undifferentiated Thyroid Cancer
Open-label, protocol designed to evaluate the activity of targeted therapy in anaplastic/undifferentiated thyroid cancer. Arm A will evaluate ATC/UTC with mutations or rearrangements detected in the ALK gene.